Fundraising Fox

Prevail Therapeutics

New York, US · Founded 2017 · Delaware corporation · 1 known investors

Healthtech

Founders & leadership

Prevail Therapeutics was founded in 2017 by ASA ABELIOVICH.

AA
ASA ABELIOVICHFounder

Board

PTPETER THOMPSON
PETER THOMPSONinBoard directorGeneral Partner at OrbiMed
MAMONA ASHIYA
MONA ASHIYAinBoard directorGeneral Partner at OrbiMed
CGCARL GORDON
CARL GORDONinBoard directorManaging Partner at OrbiMed

Investors · 1

OrbiMedreportedNew York · $1M – $75Mvia Mona Ashiya · board

Reported raises · per SEC filings

Form D private placements

$57M disclosed across 1 round · 2018

▶$57MraisedMar 2018 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • PETER THOMPSONDirector
  • MONA ASHIYADirector
  • CARL GORDONDirector
  • ASA ABELIOVICHExecutive Officer, Director
Offering amount
$65M
Amount sold
$57M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Prevail Therapeutics?
Prevail Therapeutics was founded by ASA ABELIOVICH in 2017.
Who are Prevail Therapeutics's investors?
Prevail Therapeutics's investors include OrbiMed.
How much funding has Prevail Therapeutics raised?
Prevail Therapeutics has disclosed $57M raised across 1 round.
Where is Prevail Therapeutics headquartered?
Prevail Therapeutics is headquartered in New York, US.